Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal Membrane Oxygenation
NCT07352072 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-01-29
Summary
The investigators aim to assess the risk of bleeding and thrombo-embolic complications as well as benefit and harm of blood product transfusion and anticoagulation therapy in adult ICU patients with COVID-19 supported with V-V ECMO
Conditions
- VV ECMO
- Bleeding
- Thrombosis
- Transfusion Adverse Reaction
- COVID-19
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2026-06-30
- Completion
- 2026-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
NCT04441996 ·Status: COMPLETED ·Phase: PHASE4
-
The Evaluation of Hemostasis in Hospitalized COVID-19 Patients
NCT04493307 ·Status: UNKNOWN
-
Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy
NCT02593877 ·Status: COMPLETED ·Phase: PHASE2
-
Fibrinogen Early In Severe Trauma studY
NCT02745041 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation)
NCT00748878 ·Status: COMPLETED
-
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
NCT05405426 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock
NCT02071290 ·Status: COMPLETED ·Phase: NA
-
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NCT06560164 ·Status: RECRUITING ·Phase: NA
-
Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy
NCT06582420 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage
NCT02344069 ·Status: COMPLETED ·Phase: PHASE2
-
Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections
NCT04356144 ·Status: COMPLETED
-
Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation
NCT03888833 ·Status: COMPLETED
-
Impact of a Prehospital Identification of Trauma Patients in Need for Damage Control Resuscitation.
NCT03444077 ·Status: UNKNOWN ·Phase: NA
-
Effect of Leukoreduced Blood Transfusions on Infection Following Trauma
NCT00135291 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery
NCT01530399 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer
NCT04355273 ·Status: COMPLETED ·Phase: NA
-
Rotational Thromboelastometry Activated Transfusion In Trauma Trial
NCT03765866 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil
NCT06601582 ·Status: RECRUITING ·Phase: NA
-
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
NCT02303964 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Factor In the Initial Resuscitation of Severe Trauma 2 Patients
NCT04534751 ·Status: UNKNOWN ·Phase: PHASE4
-
ROTEM in Sepsis Trauma Outcome in Intensive Care
NCT06891599 ·Status: RECRUITING
-
Point of Care Coagulation Testing in Patients Undergoing Major Surgery
NCT00656396 ·Status: COMPLETED ·Phase: PHASE3
-
Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage
NCT04149171 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients
NCT04973488 ·Status: COMPLETED ·Phase: NA
-
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
NCT02557672 ·Status: COMPLETED ·Phase: PHASE4